USP’s Diane McCarthy on the emerging standards platform and opportunities for stakeholders to help shape standards evolution.
Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...
Strategies are reshaping biologics manufacturing by boosting speed, flexibility, and productivity without expanding ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...
2d
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
The United States Patent and Trademark Office has granted the patent titled Endometriosis Biomarkers, providing intellectual ...
Seer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation ...
Matica Biotechnology, a US subsidiary of Chabiotech, has joined forces with American biotech firm Vaxdom to co-develop an ...
BioProcess International reviews key biotech trends from the first half of 2026, including US onshoring, China's biologics ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
A new genetic screening method allows researchers to efficiently modulate individual genes across entire tissues and provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results